United States · FDA National Drug Code directory
Olmesartan Medoxomil and Hydrochlorothiazide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 60290-026_5a7f1d9f-f675-e4dd-e063-6394a90a6899
- Product NDC
- 60290-026
- Form
- TABLET
- Composition / generic term
- Olmesartan Medoxomil and Hydrochlorothiazide
- Labeler
- Umedica Laboratories USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260215
- Source listing expiry
- 20271231
Source-listed ingredients
- OLMESARTAN MEDOXOMIL — 40 mg/1
- HYDROCHLOROTHIAZIDE — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (60290-026-01) · 60290-026-01
- 90 TABLET in 1 BOTTLE (60290-026-02) · 60290-026-02
- 1000 TABLET in 1 BOTTLE (60290-026-03) · 60290-026-03
- 100 TABLET in 1 BLISTER PACK (60290-026-04) · 60290-026-04
- 500 TABLET in 1 BOTTLE (60290-026-05) · 60290-026-05
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →